<p>Non-surgical cosmetic procedures have experienced significant growth, driven by advancements in technology and changing consumer demographics. The global non-surgical aesthetic market is projected to reach $90.2 billion by 2030, with Asia, particularly China, being a major contributor. Artificial Intelligence (AI) is revolutionizing these procedures by enhancing patient engagement, clinical decision-making, and operational efficiency. AI applications span from personalized aesthetic assessments and treatment planning to real-time monitoring and post-procedural care. This review synthesizes recent advancements in AI integration across the non-surgical cosmetic workflow, addressing challenges such as data privacy, algorithmic bias, and the need for comprehensive physician training. By adopting a multi-stakeholder perspective, the review highlights AI’s potential to democratize access to personalized, safe aesthetic care while emphasizing the importance of ethical considerations and regulatory frameworks.</p><p><i>Level of Evidence IV</i> This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>